[en] Nitric oxide (NO) is suggested to play a causative role in the pathogenesis of primary headaches. Infusion of NO donors can trigger headache attacks, and products of NO metabolism are found to be increased in the cranial circulation in patients suffering from such headaches. To examine if NO is involved in mediating and maintaining spinal trigeminal neuronal activity, an animal model of meningeal nociception was used. In barbiturate-anesthetized rats, a cranial window was made to expose the parietal dura mater. An access to the medullary brain stem allowed extracellular action potentials to be recorded from neurons in the spinal trigeminal nucleus that received afferent input from the exposed dura. Slow intravenous infusion of the NO donor, sodium nitroprusside (SNP, 50 microg/kg), transiently increased spontaneous activity in a subset of neurons and, with a latency of 50 min, caused a progressive increase in impulse activity across the entire sample of neurons. A similar pattern of delayed activation was seen after topical application of the same dose of SNP onto the exposed medulla. Slow injection of the nonspecific inhibitor of NO synthase, N(omega)-nitro-l-arginine methyl ester (20 mg/kg), reduced the spontaneous activity in all neurons within 15 min. The results suggest that NO can induce delayed, slowly developing activation of central trigeminal neurons and that endogenous release of NO may contribute to the ongoing activity of these neurons. The delayed changes in neuronal activity may include gene expression of pro-nociceptive mediators. These mechanisms may be relevant for the pathogenesis of chronic headaches.
Arbab MAR, Delgado T, Wiklund L, and Svendgaard NA. Brain stem terminations of the trigeminal and upper spinal innervation of the cerebrovascular system. J Cereb Blood Flow Metab 8: 54-63, 1988.
Ashina M, Bendtsen L, Jensen R, Lassen LH, Sakai F, and Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 122: 1629-1635, 1999.
Bank J. Migraine with aura after administration of sublingual nitroglycerin tablets. Headache 41: 84-87, 2001.
Brunetti L. Nitric oxide: a gas as a modulator of neuroendocrine secretions. Clin Ter 144: 147-53, 1994.
Bullitt E. Expression of C-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 296: 517-530, 1990.
Burstein R, Yamamura H, Malick A, and Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79: 964-982, 1998.
Chen JX, Berry LC, Tanner M, Chang M, Myers RP, and Meyrick B. Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium. J Cell Physiol 186: 116-123, 2001.
Dalsgaard-Nielsen T. Migraine diagnostics with special reference to pharmacological tests. Int Arch Allerg 7: 312-322, 1955.
D'Amico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi L, and Bussone G. Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? Cephalalgia 22: 33-36, 2002.
Davis KD, Meyer RA, and Campbell JN. Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. J Neurophysiol 69: 1071-1081, 1993.
De Col R, Koulchitsky SV, and Messlinger KB. Nitric oxide synthase inhibition lowers activity of neurons with meningeal input in the rat spinal trigeminal nucleus. Neuroreport 14: 229-232, 2003.
Dohrn CS and Beitz AJ. NMDA receptor mRNA expression in NOS-containing neurons in the spinal trigeminal nucleus of the rat. Neurosci Lett 175: 28-32, 1994.
Dragunow M and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29: 261-265, 1989.
Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 19: 487-493, 1968.
Feindel W, Penfield W, and McNaughton F. The tentorial nerves and localisation of intracranial pain in man. Neurology 10: 555-563, 1960.
Forster C and Handwerker HO. Automatic classification and analysis of microneurographic spike data using a PC/AT. J Neurosci Methods 31: 109-118, 1990.
Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, and Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23: 166-174, 2003.
Garthwaite JG and Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683-706, 1995.
Graham JR and Wolff HG. Mechanism of migraine headache and action of tartrate. Arch Neurol Psychiatry 38: 737-763, 1938.
Handwerker HO and Reeh PW. Pain and inflammation. In: Proceedings of the VIth World Congress on Pain, edited by Bond MR, Charlton JE, and Woolf CJ. Amsterdam: Elsevier, 1991, p. 59-70.
Holzer P, Jocic M, and Peskar BA. Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin. Br J Pharmacol 116: 2365-2370, 1995.
Honore P, Chapman V, Buritova J, and Besson J-M. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Br J Pharmacol 114: 77-84, 1995.
Ikeda S, Frank PA, Schweiss JF, and Homan SM. In vitro cyanide release from sodium nitroprusside in various intravenous solutions. Anesth Analg 4: 360-362, 1988.
Iversen HK, Olesen J, and Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17-24, 1989.
Iwamoto ET and Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 269: 699-708, 1994.
Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, and Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13: 527-536, 1992.
Jones MG, Lever I, Bingham S, Read S, McMahon SB, and Parsons A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 21: 643-655, 2001.
Kaube H, Keay KA, Hoskin KL, Bandler R, and Goadsby PJ. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629: 95-102, 1993.
Kiechle FL and Malinski T. Nitric oxide biochemistry, pathophysiology and detection. Am J Clin Pathol 100: 567-573, 1993.
Lassen LH, Ashina M, Christiansen I, Ulrich V, and Olesen J. Nitric oxide synthase inhibition in migraine. Lancet 349: 401-402, 1997.
Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, and Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18: 27-32, 1998.
Lee JH, Wilcox GL, and Beitz AJ. Nitric oxide mediates Fos expression of c-fos in the spinal cord induced by noxious stimulation. Neuroreport 3: 841-844, 1992.
Leger L, Gay N, Burlet S, Charnay Y, and Cespuglio R. Localization of nitric oxide-synthesizing neurons sending projections to the dorsal raphe nucleus of the rat. Neurosci Lett 257: 147-150, 1998.
Leong S, Liu H, and Yeo J. Nitric oxide synthase and glutamate receptor immunoreactivity in the rat spinal trigeminal neurons expressing Fos protein after formalin injection. Brain Res 855: 107-115, 2000.
Malmberg AB and Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54: 291-300, 1993.
Mayberg R, Zervas NT, and Moskowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels. J Comp Neurol 223: 45-56, 1984.
Mayer B. Regulation of nitric oxide synthase and soluble guanydil cyclase. Cell Biochem Funct 12: 167-177, 1994.
Meller ST and Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-136, 1993.
Messlinger K, Suzuki A, Pawlak M, Zehnter A, and Schmidt RF. Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat. Br J Pharmacol 129: 1397-1404, 2000.
Mizumura K, Sato J, and Kumazawa T. Effects of prostaglandins and other putative chemical intermediators on the activity of canine testicular polymodal receptors studied in vitro. Pfluegers 408: 565-572, 1987.
Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
Moore PK, Babbedge RC, Wallace P, Gaffen ZA, and Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108: 296-297, 1993.
Morgan JI and Curran T. Stimulus-transcription coupling in the nervous system. Involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14: 421-451, 1991.
Moskowitz MA and Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5: 159-177, 1993.
Olesen J, Iversen HK, and Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4: 1027-1030, 1993.
Olesen J and Jansen-Olesen I. Nitric oxide mechanisms in migraine. Pathol Biol (Paris) 48: 648-657, 2000.
Olesen J, Thomsen LL, and Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15: 149-153, 1994.
Olesen J, Thomsen LL, Lassen LH, and Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15: 94-100, 1995.
Pardutz A, Krizbai I, Multon S, Vecsei L, and Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 11: 3071-3075, 2000.
Peters GA. Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Staff Meet Mayo Clin 28: 673-686, 1953.
Pogun S and Kuhar MJ. Regulation of neurotransmitter reuptake by nitric oxide. Ann NY Acad Sci 738: 305-315, 1994.
Ray BS and Wolff HG. Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41: 813-856, 1940.
Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, Theoharides TC, Waeber C, and Moskowitz MA. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124: 2490-2502, 2001.
Riedel W. Role of nitric oxide in the control of the hypothalamic- pituitary-adrenocortical axis. Z Rheumatol 59, Suppl 2: 36-42, 2000.
Saito K, Greenberg S, and Moskowitz MA. Trigeminal origin of beta-preprotachykinin products in feline pial blood vessels. Neurosci Lett 76: 69-73, 1987.
Sarchielli P, Alberti A, Codini M, Floridi A, and Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20: 907-918, 2000.
Schepelmann K, Ebersberger A, Pawlak M, Oppmann M, and Messlinger K. Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. Neuroscience 90: 543-554, 1999.
Shimomura T, Murakami F, Kotani K, Ikawa S, and Kono S. Platelet nitric oxide metabolites in migraine. Cephalalgia 19: 218-222, 1999.
Steen KH, Reeh PW, Anton F, and Handwerker HO. Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J Neurosci 12: 86-95, 1992.
Steen KH, Steen AE, and Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin in vitro. J Neurosci 15: 3982-3989, 1995.
Stirparo G, Zicari A, Favilla M, Lipari M, and Martelletti P. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 20: 100-106, 2000.
Strassman AM, Mason P, Moskowitz MA, and Maciewicz R. Response of brain stem trigeminal neurones to electrical stimulation of the dura. Brain Res 379: 242-250, 1986.
Strassman AM and Vos BP. Somatotopic and laminar organisation of fos-like immunoreactivity in the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat. J Comp Neurol 331: 495-516, 1993.
Strassman AM, Raymond SA, and Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384: 560-564, 1996.
Strecker T, Dux M, and Messlinger K. Increase in meningeal blood flow by nitric oxide - interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibition. Cephalalgia 22: 233-241, 2002.
Tassorelli C and Joseph SA. Systemic nitroglycerin induces fos immunoreactivity in brain stem and forebrain structures of the rat. Brain Res 682: 67-78, 1995a.
Tassorelli C and Joseph SA. NADPH-diaphorase activity and fos expression in brain nuclei following nitroglycerin administration. Brain Res 695: 37-44, 1995b.
Tassorelli C, Joseph SA, and Nappi G. Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation. Neuropharmacology 36: 1417-1424, 1997.
Tassorelli C, Joseph SA, Buzzi MG, and Nappi G. The effects on the central nervous system of nitroglycerin-putative mechanisms and mediators. Prog Neurobiol 57: 607-624, 1999.
Thomsen LL, Kruuse C, Iversen HK, and Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1: 73-80, 1994.
Thomsen LL and Olesen J. Nitric oxide theory of migraine. Clin Neurosci 5: 28-33, 1998.
Uddman R, Edvinsson L, Ekman R, Kingman T, and McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62: 131-136, 1985.
Uddman R, Hara H, and Edvinsson L. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst 26: 69-75, 1989.
van der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, and Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia 22: 513-519, 2002.
Vetter G, Geisslinger G, and Tegeder I. Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain 92: 213-218, 2001.
Wang X and Robinson PJ. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 68: 443-456, 1997.
Wiertelak EP, Furness LE, Watkins LR, and Maier SF. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res 664: 9-16, 1994.
Wolff HG. Headache and Other Head Pain (2nd ed.). New York: Oxford University, 1963.
Yamamura H, Malick A, Chamberlin NL, and Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 81: 479-493, 1999.
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.
